Description: POINT Biopharma Global Inc., a late-stage clinical precision oncology company, focuses on the development and commercialization of radiopharmaceuticals for the treatment of cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic...
Description: BiomX Inc., a clinical-stage microbiome company, develops products using natural and engineered phage technologies designed to target and kill specific harmful bacteria. It targets bacteria that affect the appearance of skin, as well as chronic diseases, such as inflammatory bowel diseases (IBD), primary sclerosing cholangitis (PSC), cystic fibrosis...
Description: Gemini Therapeutics, Inc., a clinical stage precision medicine company, engages in developing various therapeutic compounds for treating genetically defined age-related macular degeneration (AMD) and linked ocular disorders. Its lead candidate is GEM103, a recombinant form of the human complement factor H protein that is in a Phase 2a trials in dry...
Two weeks ago you had the chance to buy SOFI at the SPAC price of Dec 2020. What a round trip it made! On Sunday, Superbowl LVI is hosted on the SoFi Stadium. It looks futuristic and will drive a lot of attention to its sponsor, SoFi, the online personal finance company that paid about $625 million for a 20-year naming rights deal. My short term price target...
$MP has been, for sure, one of the best SPACs when it comes to performance. SPACs got hammered multiple times. Barely did some of the known ones hold the $10 ground and some of them now are traded in $2-$3 range per share if now lower. I had a very high conviction on $MP from its DA announcement and I am holding it from before the merger. Today, I see more...
Trump's TRUTH Social platform is now expected to launch by March 31 versus previously announced launch date of February 21
Shares of NASDAQ:DWAC , Donald Trump's media SPAC, have rallied off a Spike Alert on January 6th and were up 100% from the bottom. I'm looking at 92.47 as potential resistance.
IPOF has been trading sideways for most of the year and recently started to reverse on the daily chart IPOF is trying to trade above the Moving Averages first price target is $10.80 2nd Price target $11.50 if Chamath can land DISCORD or STARLINK $IPOF will moon Apes will buy
$IONQ style falling at the beginning of trading. Yet the company has a great future and killed sentiment. If we see recover here. it will shoot to 20+ in next 2 months, just like $IONQ did. p.s. similarities do work.
Benessere Capital Acquisition Corp, a SPAC, and eCombustible Energy LLC, a leading innovator and provider of customizable hydrogen-based fuel for thermal industrial applications announced that the companies have entered into a definitive business combination agreement, providing for a business combination that will result in eCombustible Energy becoming a public...
$IPOF after 1 year looks like it has found bottom and has been consolidating just above NAV for a few weeks/months of $10.00 not much will happen without a confirmed acquisition target could be a good place to park some cash while market is volatile with rumours of Starlink/Discord and the success of the All In Podcasts this has real potential but nothing is...
Symbotic LLC — a revolutionary A.I.-enabled technology platform for the supply chain — and SVF Investment Corp. 3 (NASDAQ: SVFC) — a special purpose acquisition company sponsored by an affiliate of SoftBank Investment Advisers (SBIA) — announced today a definitive merger agreement expected to make Symbotic a public company listed on Nasdaq. Upon the completion of...
If you haven`t bought it before the $180 pump: or after the retracement and short term price target: Then you should know that DWAC had received a $1 billion investment from a group of institutional investors. Coincidentally or not, Saba Capital Management announced on Dec. 9 that it had purchased a stake in DWAC. Now that Jack Dorsey has left Twitter, i think...
$INDI did as I expected in my last post on $INDI. Considering the general tax selling sell-off in the market towards the end of the year it is possible that it is headed to its main support area around $11, which is nearly 200SMA today. This is a drastic pullback, but SPACs have not found their firm stepping stone to higher prices yet.
Rumble platform growth from 1.6 million average monthly active users in Q3 2020 to a record 36 million average monthly active users in Q3 2021. 44 million monthly active users in August 2021. CFVI merger transaction values Rumble at an enterprise value of $2.1 billion. Do you see more upside from here?
Gores Guggenheim, Inc. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. The company was founded in 2020 and is based in Boulder, Colorado.
Opendoor $OPEN has delivered better than expected results in the past 2 QE. The fundamentals are strong and this past sell-off was due to the broad market sell-off. At $13.50-$13.75 range we have a strong support area that should hold. If so the minimum rise should be the resistance area of the range-bound rectangle at around $18.50. Entering a BUY position at...
$CFVI as expected, Rumble and Trump’s social media venture $DWAC have been in talks about a potential business partnership... 1.6 Million active users in Q3 2020 to 36 Million active users in Q3 2020 2150% increase in one year!!! This is not a $12 SPAC, also the deal is worth 15% of Rumble, that’s high for a SPAC deal...